Not yet recruiting
Parkinson's disease
Not yet recruitingCognitive effects of a three‑month methylphenidate course in Parkinson's disease patients with mild cognitive impairment
Registered drug
Cognitive effects of a three‑month methylphenidate course in Parkinson's disease patients with mild cognitive impairment
Registered drug
- Disease:Parkinson's disease
- Substances:Methylphenidate Hydrochloride
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Methylphenidate Hydrochloride
- Sponsor:Universidad Rey Juan Carlos
